Graham Clews

1 week ago | pharmaceutical-journal.com | Graham Clews

A staggering 4,790 people died as a result of drug misuse in Great Britain in 2023, according to the most recent data from the Office for National Statistics (ONS). ONS figures reveal that there were 3,618 drug-misuse deaths in England and Wales in 2023 — a 16% increase from 3,127 drug-misuse deaths in 2022.

1 month ago | pharmaceutical-journal.com | Graham Clews

The government has announced that prescription charges in England are to be frozen for the first time in three years. In a statement published on 28 April 2025, the government announced that the prescription charge for 2025/2026 will remain at £9.90 per item, a three-month prescription prepayment certificate will be frozen at £32.05, and a 12-month certificate will stay at £114.50. Prescription fees were most recently frozen in 2022, which at that point was the first time in a decade.

2 months ago | pharmaceutical-journal.com | Graham Clews

Community pharmacies in England have had their funding boosted by £617m over the next two years, following agreement on a new two-year contract. In a statement published on 31 March 2025, Community Pharmacy England (CPE) said overall funding for community pharmacy would rise in 2025/2026 to more than £3bn per year for the first time.

2 months ago | pharmaceutical-journal.com | Graham Clews

Royal Pharmaceutical Society (RPS) members have voted in favour of becoming a royal college. The results of a special resolution vote, announced on 26 March 2025, show that 71.1% of members voted to support proposed changes to the RPS’s Royal Charter and a transition to royal college status.

Jan 22, 2025 | pharmaceutical-journal.com | Graham Clews |Sophie Willis

Speaking during a debate in the House of Commons in November 2024, Kim Leadbeater, Labour MP for Spen Valley, West Yorkshire, described a surge of public opinion in favour of the legalisation of assisted dying for terminally ill patients.